FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1987311000001106: Erythroped Forte SF 500mg/5ml suspension (Abbott Laboratories Ltd) 140 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
24893701000001117 Erythroped Forte SF 500mg/5ml suspension (Abbott Laboratories Ltd) 140 ml (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
111569201000001110 Erythroped Forte SF 500mg/5ml oral suspension (Advanz Pharma) 140 ml en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Erythroped Forte SF 500mg/5ml suspension (Abbott Laboratories Ltd) 140 ml Is a Erythromycin ethyl succinate 500mg/5ml oral suspension sugar free 140 ml true Inferred relationship Existential restriction modifier
Erythroped Forte SF 500mg/5ml suspension (Abbott Laboratories Ltd) 140 ml Is pack of Erythroped Forte SF 500mg/5ml suspension (Abbott Laboratories Ltd) false Inferred relationship Existential restriction modifier
Erythroped Forte SF 500mg/5ml suspension (Abbott Laboratories Ltd) 140 ml Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Erythroped Forte SF 500mg/5ml suspension (Abbott Laboratories Ltd) 140 ml Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Erythroped Forte SF 500mg/5ml suspension (Abbott Laboratories Ltd) 140 ml Has active ingredient Erythromycin ethylsuccinate false Inferred relationship Existential restriction modifier
Erythroped Forte SF 500mg/5ml suspension (Abbott Laboratories Ltd) 140 ml Has active ingredient Erythromycin false Inferred relationship Existential restriction modifier
Erythroped Forte SF 500mg/5ml suspension (Abbott Laboratories Ltd) 140 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Erythroped Forte SF 500mg/5ml suspension (Abbott Laboratories Ltd) 140 ml Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Erythroped Forte SF 500mg/5ml suspension (Abbott Laboratories Ltd) 140 ml Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Erythroped Forte SF 500mg/5ml suspension (Abbott Laboratories Ltd) 140 ml Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Erythroped Forte SF 500mg/5ml suspension (Abbott Laboratories Ltd) 140 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Erythroped Forte SF 500mg/5ml suspension (Abbott Laboratories Ltd) 140 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Erythroped Forte SF 500mg/5ml suspension (Abbott Laboratories Ltd) 140 ml Has manufactured dose form Conventional release oral suspension false Inferred relationship Existential restriction modifier
Erythroped Forte SF 500mg/5ml suspension (Abbott Laboratories Ltd) 140 ml Has AMP Erythroped Forte SF 500mg/5ml suspension (Abbott Laboratories Ltd) true Inferred relationship Existential restriction modifier
Erythroped Forte SF 500mg/5ml suspension (Abbott Laboratories Ltd) 140 ml Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Erythromycin true Inferred relationship Existential restriction modifier
Erythroped Forte SF 500mg/5ml suspension (Abbott Laboratories Ltd) 140 ml Has specific active ingredient Erythromycin ethylsuccinate true Inferred relationship Existential restriction modifier
Erythroped Forte SF 500mg/5ml suspension (Abbott Laboratories Ltd) 140 ml Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Erythroped Forte SF 500mg/5ml suspension (Abbott Laboratories Ltd) 140 ml Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Erythroped Forte SF 500mg/5ml suspension (Abbott Laboratories Ltd) 140 ml Has basis of strength substance Erythromycin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start